Arena Pharmaceuticals Stock Net Income
Arena Pharmaceuticals fundamentals help investors to digest information that contributes to Arena Pharmaceuticals' financial success or failures. It also enables traders to predict the movement of Arena Stock. The fundamental analysis module provides a way to measure Arena Pharmaceuticals' intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Arena Pharmaceuticals stock.
Arena |
Arena Pharmaceuticals Company Net Income Analysis
Arena Pharmaceuticals' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Arena Pharmaceuticals Net Income | (616.43 M) |
Most of Arena Pharmaceuticals' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Arena Pharmaceuticals is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
CompetitionBased on the recorded statements, Arena Pharmaceuticals reported net income of (616.43 Million). This is 280.62% lower than that of the Healthcare sector and significantly lower than that of the Biotechnology industry. The net income for all United States stocks is significantly higher than that of the company.
Arena Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Arena Pharmaceuticals' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Arena Pharmaceuticals could also be used in its relative valuation, which is a method of valuing Arena Pharmaceuticals by comparing valuation metrics of similar companies.Arena Pharmaceuticals is currently under evaluation in net income category among related companies.
Arena Fundamentals
| Return On Equity | -70.3 | |||
| Return On Asset | -34.53 | |||
| Current Valuation | 5.36 B | |||
| Shares Outstanding | 61.56 M | |||
| Shares Owned By Insiders | 0.55 % | |||
| Shares Owned By Institutions | 84.05 % | |||
| Number Of Shares Shorted | 5.11 M | |||
| Price To Earning | 4.53 X | |||
| Price To Book | 7.65 X | |||
| Revenue | 54 K | |||
| Gross Profit | (419.45 M) | |||
| EBITDA | (541.79 M) | |||
| Net Income | (616.43 M) | |||
| Cash And Equivalents | 550.47 M | |||
| Cash Per Share | 8.93 X | |||
| Total Debt | 51.31 M | |||
| Debt To Equity | 0.08 % | |||
| Current Ratio | 8.59 X | |||
| Book Value Per Share | 13.07 X | |||
| Cash Flow From Operations | (452.02 M) | |||
| Short Ratio | 3.83 X | |||
| Earnings Per Share | (9.72) X | |||
| Price To Earnings To Growth | 0.46 X | |||
| Number Of Employees | 448 | |||
| Beta | 0.55 | |||
| Market Capitalization | 6.16 B | |||
| Total Asset | 256.79 M | |||
| Retained Earnings | (1.19 B) | |||
| Working Capital | 124.94 M | |||
| Current Asset | 174.84 M | |||
| Current Liabilities | 49.9 M | |||
| Z Score | 59.8 |
Pair Trading with Arena Pharmaceuticals
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Arena Pharmaceuticals position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Arena Pharmaceuticals will appreciate offsetting losses from the drop in the long position's value.The ability to find closely correlated positions to Fiserv could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Fiserv when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Fiserv - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Fiserv Inc to buy it.
The correlation of Fiserv is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Fiserv moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Fiserv Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Fiserv can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. You can also try the Portfolio Manager module to state of the art Portfolio Manager to monitor and improve performance of your invested capital.
Other Consideration for investing in Arena Stock
If you are still planning to invest in Arena Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Arena Pharmaceuticals' history and understand the potential risks before investing.
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| AI Investment Finder Use AI to screen and filter profitable investment opportunities |